Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
Titel:
Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
Auteur:
Martenyi, Ferenc Zavadenko, Nikolay N. Jarkova, Natalia B. Yarosh, Alexandr A. Soldatenkova, Victoria O. Bardenstein, Leonid M. Kozlova, Irina A. Neznanov, Nikolay G. Maslova, Olga I. Petrukhin, Andrey S. Sukchotina, Nina K. Zykov, Valeriy P.